Damit die Landwirtschaft auch in Zukunft die Menschheit ernähren kann, ohne dabei die Umwelt zu zerstören, setzen manche ...

With new funding, Tolemy Bio plans to advance its AI-enabled cell biology platform designed to help biopharma teams better ...

From Genryo’s Sidewinder technology to the Festival of Genomics & Biodata in the UK earlier this year – AI might be trending, ...

Bio-Techne Corporation ( TECH) Q3 2026 Earnings Call May 6, 2026 9:00 AM EDT Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Third Quarter and Fiscal Year 2026. [Operator ...

Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940 $93 million in cash provides runway through expected clinical proof-of-concept readout for KOMODO-1 SAN DIEGO, May 08, 2026 ...

Jon Stokes, Chris Sinclair and Jeff Skinner led Stoked Bio announced $2.5M seed round of financing with private investors ...

INmune Bio Inc. (NASDAQ: INMB), a late-stage biotechnology company focused on inflammation and immunology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

Bio-Techne (NASDAQ:TECH) reported fiscal third-quarter 2026 results marked by uneven end-market conditions, with strong ...

INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing therapies that target innate immune dysfunction, today announced that results from its Phase 2 MINDFuL trial in ...

"We expect organic growth in the fourth quarter to be approximately flat" and added that "excluding the impact of the cell therapy headwinds, we anticipate low single-digit underlying growth across ...

Robust B-cell depletion observed with budoprutug subcutaneous formulation in healthy volunteers, supporting continued ...

IU locked down the laboratory of Distinguished Professor of Biology Roger Innes on Thursday night, according to an email sent ...